Sheila Gujrathi reports stock transactions at BOLT
By AlphaYouPublished Form 4
GUJRATHI SHEILA
Reporting filer
Sheila Gujrathi reports stock transactions, not an open-market purchase or sale, in Bolt Biotherapeutics, Inc.. Form 4 filed Oct 27, 2026 lists 4 entries.
- Disclosed
- Oct 27, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | GUJRATHI SHEILA | 2026-10-23 | A | Grant or award | 72766 | 0 | 72,766 | 4 days | Filed terms
|
| Common Stock | GUJRATHI SHEILA | 2026-10-23 | A | Grant or award | 13055 | 0 | 13,055 | 4 days | Filed terms
|
| Series D Preferred Stock (derivative) | GUJRATHI SHEILA | 2026-10-23 | J | Other (see filing) | 2763.833 | Not stated (see footnotes) | 2,763.833 | 4 days | Filed terms
|
| Series D Preferred Stock (derivative) | GUJRATHI SHEILA | 2026-10-23 | J | Other (see filing) | 495.874 | Not stated (see footnotes) | 495.874 | 4 days | Filed terms
|
Common Stock
- Owner
- GUJRATHI SHEILA
- Date
- 2026-10-23
- Code
- A
- Action
- Grant or award
- Quantity
- 72766
- Price
- 0
- Following holdings
- 72,766
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-23
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- id: F1
- id: F2
- transaction Shares: 72766
- transaction Price Per Share: 0
- id: F1
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 72766
- direct Or Indirect Ownership: D
Common Stock
- Owner
- GUJRATHI SHEILA
- Date
- 2026-10-23
- Code
- A
- Action
- Grant or award
- Quantity
- 13055
- Price
- 0
- Following holdings
- 13,055
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-23
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- id: F1
- id: F2
- transaction Shares: 13055
- transaction Price Per Share: 0
- id: F1
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 13055
- direct Or Indirect Ownership: I
- nature Of Ownership: By SilverArc Private Fund I, L.P.
- id: F3
Series D Preferred Stock (derivative)
- Owner
- GUJRATHI SHEILA
- Date
- 2026-10-23
- Code
- J
- Action
- Other (see filing)
- Quantity
- 2763.833
- Price
- Not stated (see footnotes)
- Following holdings
- 2,763.833
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Series D Preferred Stock
- id: F4
- transaction Date: 2026-10-23
- id: F4
- transaction Form Type: 4
- transaction Code: J
- equity Swap Involved: false
- transaction Shares: 2763.833
- id: F1
- id: F2
- transaction Acquired Disposed Code: A
- id: F4
- id: F4
- underlying Security Title: Common Stock
- underlying Security Shares: 2763833
- shares Owned Following Transaction: 2763.833
- direct Or Indirect Ownership: D
Series D Preferred Stock (derivative)
- Owner
- GUJRATHI SHEILA
- Date
- 2026-10-23
- Code
- J
- Action
- Other (see filing)
- Quantity
- 495.874
- Price
- Not stated (see footnotes)
- Following holdings
- 495.874
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Series D Preferred Stock
- id: F4
- transaction Date: 2026-10-23
- transaction Form Type: 4
- transaction Code: J
- equity Swap Involved: false
- id: F4
- transaction Shares: 495.874
- id: F1
- id: F2
- transaction Acquired Disposed Code: A
- id: F4
- id: F4
- underlying Security Title: Common Stock
- underlying Security Shares: 495874
- shares Owned Following Transaction: 495.874
- direct Or Indirect Ownership: I
- nature Of Ownership: By SilverArc Private Fund I, L.P.
- id: F3
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- GUJRATHI SHEILA: Chief Strategy Officer, Director.
- F1: Received in exchange for shares of common stock of Prana Therapies, Inc. ("Prana") pursuant to the Agreement and Plan of Merger dated October 23, 2026 (the "Merger Agreement") by and among the Issuer, Prana, Prince Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("Merger Sub I"), Prince Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer ("Merger Sub II"). Each outstanding share of Prana common stock was converted into the right to receive 1.6413 shares of the Issuer's common stock or common-stock equivalents, consisting of Issuer's common stock and Series D Convertible Preferred Stock ("Series D Preferred") convertible at a rate of 1,000 shares of Issuer's common stock per share of Series D Preferred. No cash purchase price was paid for the Series D Preferred received as merger consideration.
- F2: Upon closing of the merger on October 23, 2026, Prana shares held directly by the Reporting Person converted into 72,766 shares of Issuer's common stock and 2,763.833 shares of Series D Preferred. Prana shares held by SilverArc Private Fund I, L.P. converted into 13,055 shares of Issuer's common stock and 495.874 shares of Series D Preferred. The 495.874 shares of Series D Preferred constitute merger consideration
- F3: The Reporting Person is Co-Portfolio Manager and has membership interest in SilverArc Private Capital I, LLC (Ultimate General Partner), SilverArc Private Capital I, LP (General Partner), and SilverArc Private Capital Management I, LP (Management Company) for SilverArc Private Fund I, L.P. The Reporting Person may not be deemed to have voting or investment power over the shares held of record by SilverArc Private Fund I, LP. The Reporting Person disclaims beneficial ownership of the Non-Derivative and Derivative securities held of record by SilverArc Private Fund I, L.P., except to the extent of any pecuniary interest therein.
- F4: Each share of Series D Preferred is convertible into 1,000 shares of the Issuer's common stock, subject to the conditions set forth in the Certificate of Designation, including receipt of the requisite stockholder approval. The Series D Preferred has no expiration date.
Original sources
Prepared automatically from public filing data. Report a correction.